Ensysce Biosciences, Inc. (ENSC) › Total LiabilitiesEnsysce Biosciences, Inc. (ENSC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $12.82M2018: $13.17M2019: $17.50M2020: $7.01M2021: $24.58M2022: $9.91M2023: $3.36M2024: $2.22M2025: $4.57M$4.57M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$4.57M+106.0%2024$2.22M-34.0%2023$3.36M-66.1%2022$9.91M-59.7%2021$24.58M+250.6%2020$7.01M-59.9%2019$17.50M+32.9%2018$13.17M+2.7%2017$12.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share